Certis Oncology Solutions

Certis Oncology Solutions (Certis), a translational science and precision oncology company, today announced it has been selected as "Overall Immunology Company of the Year" in the third annual BioTech Breakthrough Awards program conducted by BioTech Breakthrough.

Certis Oncology Solutions announced plans to offer its personalized drug efficacy testing to the pharmaceutical industry. Debbie Snyder-Stanton joined the company as vice president of pharmaceutical business development.

Certis Oncology Solutions, a clinical research organization (CRO) and precision cancer therapy company, announced today it is offering mobile COVID-19 testing services to area businesses.

Certis Oncology Solutions combines functional assays and artificial intelligence to advance personalized medicine. The company announced that an abstract was accepted for presentation at the Society for Immunotherapy of Cancer (SITC) Annual Meeting.

Certis Oncology is a licensed California clinical laboratory with CLIA, AAALAC and OLAW certifications.

Genetic testing (NGS) can provide clues about which drugs might be effective against an individual's cancer and help inform decisions about drugs to test in mouse avatars. It is not required for the functional oncology drug sensitivity test.

In vitro testing can provide clues about which drugs might be effective against an individual's cancer and help inform decisions about drugs to test in mouse avatars. It is not required for in vivo pharmacology testing.

In vitro testing can provide clues about which drugs might be effective against an individual's cancer and help inform decisions about drugs to test in mouse avatars. It is not required for YourPDX in vivo pharmacology testing.

Genomic profiling, in vitro testing and in silico modeling can provide insight into therapies that might lead to a positive clinical response. These technologies are complementary to the functional oncology testing at Certis.

The story behind Certis and the BarneyOI cancer model database begins with a son diagnosed with liposarcoma.

Certis Oncology is a life science technology company with a mission to realize the promise of precision oncology.

The story behind Certis and the BarneyOI Cancer Model Database begins with a son diagnosed with liposarcoma.

Certis Oncology is a life science technology company. Its Certis Oncology Intelligence product provides therapeutic response data derived from biological models of cancer and AI-driven bioinformatics.

Certis Oncology Intelligence: predictive AI + advanced cancer models for more insightful data. Translational science, done differently.

This statement of privacy policy covers how this site handles personal data collected by website visitors.